InvestorsObserver
×
News Home

Does Zymeworks Inc (ZYME) Have What it Takes to be in Your Portfolio Monday?

Monday, September 13, 2021 01:15 PM | InvestorsObserver Analysts

Mentioned in this article

Does Zymeworks Inc (ZYME) Have What it Takes to be in Your Portfolio Monday?

A rating of 83 puts Zymeworks Inc (ZYME) near the top of the Biotechnology industry according to InvestorsObserver. Zymeworks Inc's score of 83 means it scores higher than 83% of stocks in the industry. Zymeworks Inc also received an overall rating of 54, putting it above 54% of all stocks. Biotechnology is ranked 93 out of the 148 industries.

Overall Score - 54
ZYME has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on ZYME!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Zymeworks Inc Stock Today?

Zymeworks Inc (ZYME) stock is trading at $33.89 as of 1:09 PM on Monday, Sep 13, a gain of $1.48, or 4.57% from the previous closing price of $32.41. Volume today is above average. So far 1,514,386 shares have traded compared to average volume of 309,152 shares. The stock has traded between $32.93 and $34.29 so far today. Click Here to get the full Stock Report for Zymeworks Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App